Goldman Sachs’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-28,178
Closed -$138K 5266
2025
Q1
$138K Sell
28,178
-24,094
-46% -$118K ﹤0.01% 4761
2024
Q4
$351K Buy
52,272
+22,495
+76% +$151K ﹤0.01% 4461
2024
Q3
$230K Sell
29,777
-72,141
-71% -$558K ﹤0.01% 4445
2024
Q2
$612K Buy
101,918
+61,447
+152% +$369K ﹤0.01% 3850
2024
Q1
$365K Sell
40,471
-3,801
-9% -$34.3K ﹤0.01% 4115
2023
Q4
$419K Sell
44,272
-94,229
-68% -$893K ﹤0.01% 4045
2023
Q3
$1.65M Buy
138,501
+4,004
+3% +$47.6K ﹤0.01% 3212
2023
Q2
$3.3M Buy
134,497
+26,287
+24% +$644K ﹤0.01% 2863
2023
Q1
$3.39M Buy
108,210
+62,884
+139% +$1.97M ﹤0.01% 2832
2022
Q4
$3.19M Sell
45,326
-50,033
-52% -$3.52M ﹤0.01% 2958
2022
Q3
$8.21M Buy
95,359
+27,102
+40% +$2.33M ﹤0.01% 2275
2022
Q2
$5.65M Buy
68,257
+42,337
+163% +$3.5M ﹤0.01% 2563
2022
Q1
$4.31M Buy
25,920
+17,300
+201% +$2.87M ﹤0.01% 2914
2021
Q4
$1.44M Sell
8,620
-18,754
-69% -$3.14M ﹤0.01% 3743
2021
Q3
$2.37M Buy
27,374
+15,718
+135% +$1.36M ﹤0.01% 3346
2021
Q2
$633K Buy
11,656
+1,521
+15% +$82.6K ﹤0.01% 4306
2021
Q1
$604K Buy
10,135
+1,270
+14% +$75.7K ﹤0.01% 4230
2020
Q4
$462K Buy
8,865
+1,416
+19% +$73.8K ﹤0.01% 3864
2020
Q3
$360K Buy
7,449
+2,047
+38% +$98.9K ﹤0.01% 3811
2020
Q2
$280K Buy
5,402
+3,416
+172% +$177K ﹤0.01% 3858
2020
Q1
$87K Buy
1,986
+149
+8% +$6.53K ﹤0.01% 4191
2019
Q4
$74K Sell
1,837
-2,530
-58% -$102K ﹤0.01% 4169
2019
Q3
$143K Buy
4,367
+2,910
+200% +$95.3K ﹤0.01% 3998
2019
Q2
$112K Buy
+1,457
New +$112K ﹤0.01% 3980
2018
Q3
Sell
-2,500
Closed -$433K 4188
2018
Q2
$433K Buy
+2,500
New +$433K ﹤0.01% 3590